Search
for
Sort by
Research 781–810 of 1000+
- Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems
- Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia
- Intracavernous injection of platelet‐rich plasma reverses erectile dysfunction of chronic cavernous nerve degeneration through reduction of prostate hyperplasia evidence from an aging‐induced erectile dysfunction rat model
- Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery
- Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends
- Vitamin B <sub>12</sub> Deficiency: A Rare Cause of Excessive Daytime Sleepiness
- Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)
- Pharmacovigilance in Pediatric Patients with Epilepsy Using Antiepileptic Drugs
- PolyQ length co-evolution in neural proteins
- Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Fabrication of Thymoquinone and Ascorbic Acid-Loaded Spanlastics Gel for Hyperpigmentation: In Vitro Release, Cytotoxicity, and Skin Permeation Studies
- Short- and mid-term outcomes of multisystem inflammatory syndrome in children: a longitudinal prospective single-center cohort study
- Mesenchymal stem cell‐derived exosomes for organ development and cell‐free therapy
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- Obesity and Wound Healing: Focus on Mesenchymal Stem Cells
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Causes and therapeutic limitations of clinical alopecia and the advent of human pluripotent stem cell follicular transplantation
- Depressive Disorder and Dermatological Autoimmune Diseases
- Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar‐I disorder: A double‐blind, randomized, placebo‐controlled clinical trial
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease
- Past, Present, and Future of Plant-Derived Extracellular Vesicles in Biomedical Applications
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Photobiomodulation for the treatment of knee osteoarthritis: therapeutic effects and molecular mechanism
- Hair Cortisol as a Biomarker of Chronic Stress in Community-Dwelling Adults With Longstanding Multiple Sclerosis
- Real‐World Clinical Outcomes With a 1% SeleniumSulfide/1% Salicylic Acid Shampoo Formulation for Seborrheic Dermatitis and Dandruff: A Multicenter Observational Study
- The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients